img

Global Vigabatrin Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Vigabatrin Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Vigabatrin is a medication used to treat epilepsy. It became available as a generic medication in 2019. It works by inhibiting the breakdown of γ-aminobutyric acid (GABA). It is also known as γ-vinyl-GABA, and is a structural analogue of GABA, but does not bind to GABA receptors.
Vigabatrin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Vigabatrin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Infantile Spasms (IS) and Partial-Onset Seizures are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Vigabatrin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Vigabatrin key manufacturers include Sanofi, Benta Pharma Industries, Dr. Fisher Farma, Lundbeck, Novartis, Perrigo, Grindeks, Endo International and Amneal Pharma, etc. Sanofi, Benta Pharma Industries, Dr. Fisher Farma are top 3 players and held % sales share in total in 2022.
Vigabatrin can be divided into Tablet and Powder, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Vigabatrin is widely used in various fields, such as Infantile Spasms (IS), Partial-Onset Seizures and Refractory Complex Partial Seizures,, etc. Infantile Spasms (IS) provides greatest supports to the Vigabatrin industry development. In 2022, global % sales of Vigabatrin went into Infantile Spasms (IS) filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vigabatrin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
Benta Pharma Industries
Dr. Fisher Farma
Lundbeck
Novartis
Perrigo
Grindeks
Endo International
Amneal Pharma
Cipla
Upsher-Smith
Segment by Type
Tablet
Powder

Segment by Application


Infantile Spasms (IS)
Partial-Onset Seizures
Refractory Complex Partial Seizures

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Vigabatrin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Vigabatrin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Vigabatrin industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Vigabatrin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Vigabatrin introduction, etc. Vigabatrin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Vigabatrin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Vigabatrin Market Overview
1.1 Vigabatrin Product Overview
1.2 Vigabatrin Market Segment by Type
1.2.1 Tablet
1.2.2 Powder
1.3 Global Vigabatrin Market Size by Type
1.3.1 Global Vigabatrin Market Size Overview by Type (2024-2034)
1.3.2 Global Vigabatrin Historic Market Size Review by Type (2024-2024)
1.3.3 Global Vigabatrin Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vigabatrin Sales Breakdown by Type (2024-2024)
1.4.2 Europe Vigabatrin Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Vigabatrin Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Vigabatrin Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Vigabatrin Sales Breakdown by Type (2024-2024)
2 Global Vigabatrin Market Competition by Company
2.1 Global Top Players by Vigabatrin Sales (2024-2024)
2.2 Global Top Players by Vigabatrin Revenue (2024-2024)
2.3 Global Top Players by Vigabatrin Price (2024-2024)
2.4 Global Top Manufacturers Vigabatrin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vigabatrin Market Competitive Situation and Trends
2.5.1 Vigabatrin Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Vigabatrin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vigabatrin as of 2022)
2.7 Date of Key Manufacturers Enter into Vigabatrin Market
2.8 Key Manufacturers Vigabatrin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vigabatrin Status and Outlook by Region
3.1 Global Vigabatrin Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Vigabatrin Historic Market Size by Region
3.2.1 Global Vigabatrin Sales in Volume by Region (2024-2024)
3.2.2 Global Vigabatrin Sales in Value by Region (2024-2024)
3.2.3 Global Vigabatrin Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Vigabatrin Forecasted Market Size by Region
3.3.1 Global Vigabatrin Sales in Volume by Region (2024-2034)
3.3.2 Global Vigabatrin Sales in Value by Region (2024-2034)
3.3.3 Global Vigabatrin Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Vigabatrin by Application
4.1 Vigabatrin Market Segment by Application
4.1.1 Infantile Spasms (IS)
4.1.2 Partial-Onset Seizures
4.1.3 Refractory Complex Partial Seizures
4.2 Global Vigabatrin Market Size by Application
4.2.1 Global Vigabatrin Market Size Overview by Application (2024-2034)
4.2.2 Global Vigabatrin Historic Market Size Review by Application (2024-2024)
4.2.3 Global Vigabatrin Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vigabatrin Sales Breakdown by Application (2024-2024)
4.3.2 Europe Vigabatrin Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Vigabatrin Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Vigabatrin Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Vigabatrin Sales Breakdown by Application (2024-2024)
5 North America Vigabatrin by Country
5.1 North America Vigabatrin Historic Market Size by Country
5.1.1 North America Vigabatrin Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Vigabatrin Sales in Volume by Country (2024-2024)
5.1.3 North America Vigabatrin Sales in Value by Country (2024-2024)
5.2 North America Vigabatrin Forecasted Market Size by Country
5.2.1 North America Vigabatrin Sales in Volume by Country (2024-2034)
5.2.2 North America Vigabatrin Sales in Value by Country (2024-2034)
6 Europe Vigabatrin by Country
6.1 Europe Vigabatrin Historic Market Size by Country
6.1.1 Europe Vigabatrin Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Vigabatrin Sales in Volume by Country (2024-2024)
6.1.3 Europe Vigabatrin Sales in Value by Country (2024-2024)
6.2 Europe Vigabatrin Forecasted Market Size by Country
6.2.1 Europe Vigabatrin Sales in Volume by Country (2024-2034)
6.2.2 Europe Vigabatrin Sales in Value by Country (2024-2034)
7 Asia-Pacific Vigabatrin by Region
7.1 Asia-Pacific Vigabatrin Historic Market Size by Region
7.1.1 Asia-Pacific Vigabatrin Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Vigabatrin Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Vigabatrin Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Vigabatrin Forecasted Market Size by Region
7.2.1 Asia-Pacific Vigabatrin Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Vigabatrin Sales in Value by Region (2024-2034)
8 Latin America Vigabatrin by Country
8.1 Latin America Vigabatrin Historic Market Size by Country
8.1.1 Latin America Vigabatrin Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Vigabatrin Sales in Volume by Country (2024-2024)
8.1.3 Latin America Vigabatrin Sales in Value by Country (2024-2024)
8.2 Latin America Vigabatrin Forecasted Market Size by Country
8.2.1 Latin America Vigabatrin Sales in Volume by Country (2024-2034)
8.2.2 Latin America Vigabatrin Sales in Value by Country (2024-2034)
9 Middle East and Africa Vigabatrin by Country
9.1 Middle East and Africa Vigabatrin Historic Market Size by Country
9.1.1 Middle East and Africa Vigabatrin Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Vigabatrin Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Vigabatrin Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Vigabatrin Forecasted Market Size by Country
9.2.1 Middle East and Africa Vigabatrin Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Vigabatrin Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Vigabatrin Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Sanofi Vigabatrin Products Offered
10.1.5 Sanofi Recent Development
10.2 Benta Pharma Industries
10.2.1 Benta Pharma Industries Company Information
10.2.2 Benta Pharma Industries Introduction and Business Overview
10.2.3 Benta Pharma Industries Vigabatrin Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Benta Pharma Industries Vigabatrin Products Offered
10.2.5 Benta Pharma Industries Recent Development
10.3 Dr. Fisher Farma
10.3.1 Dr. Fisher Farma Company Information
10.3.2 Dr. Fisher Farma Introduction and Business Overview
10.3.3 Dr. Fisher Farma Vigabatrin Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Dr. Fisher Farma Vigabatrin Products Offered
10.3.5 Dr. Fisher Farma Recent Development
10.4 Lundbeck
10.4.1 Lundbeck Company Information
10.4.2 Lundbeck Introduction and Business Overview
10.4.3 Lundbeck Vigabatrin Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Lundbeck Vigabatrin Products Offered
10.4.5 Lundbeck Recent Development
10.5 Novartis
10.5.1 Novartis Company Information
10.5.2 Novartis Introduction and Business Overview
10.5.3 Novartis Vigabatrin Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Novartis Vigabatrin Products Offered
10.5.5 Novartis Recent Development
10.6 Perrigo
10.6.1 Perrigo Company Information
10.6.2 Perrigo Introduction and Business Overview
10.6.3 Perrigo Vigabatrin Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Perrigo Vigabatrin Products Offered
10.6.5 Perrigo Recent Development
10.7 Grindeks
10.7.1 Grindeks Company Information
10.7.2 Grindeks Introduction and Business Overview
10.7.3 Grindeks Vigabatrin Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Grindeks Vigabatrin Products Offered
10.7.5 Grindeks Recent Development
10.8 Endo International
10.8.1 Endo International Company Information
10.8.2 Endo International Introduction and Business Overview
10.8.3 Endo International Vigabatrin Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Endo International Vigabatrin Products Offered
10.8.5 Endo International Recent Development
10.9 Amneal Pharma
10.9.1 Amneal Pharma Company Information
10.9.2 Amneal Pharma Introduction and Business Overview
10.9.3 Amneal Pharma Vigabatrin Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Amneal Pharma Vigabatrin Products Offered
10.9.5 Amneal Pharma Recent Development
10.10 Cipla
10.10.1 Cipla Company Information
10.10.2 Cipla Introduction and Business Overview
10.10.3 Cipla Vigabatrin Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Cipla Vigabatrin Products Offered
10.10.5 Cipla Recent Development
10.11 Upsher-Smith
10.11.1 Upsher-Smith Company Information
10.11.2 Upsher-Smith Introduction and Business Overview
10.11.3 Upsher-Smith Vigabatrin Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Upsher-Smith Vigabatrin Products Offered
10.11.5 Upsher-Smith Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vigabatrin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vigabatrin Industrial Chain Analysis
11.4 Vigabatrin Market Dynamics
11.4.1 Vigabatrin Industry Trends
11.4.2 Vigabatrin Market Drivers
11.4.3 Vigabatrin Market Challenges
11.4.4 Vigabatrin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vigabatrin Distributors
12.3 Vigabatrin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Tablet
Table 2. Major Company of Powder
Table 3. Global Vigabatrin Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Vigabatrin Sales by Type (2024-2024) & (K Units)
Table 5. Global Vigabatrin Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Vigabatrin Sales by Type (2024-2024) & (US& Million)
Table 7. Global Vigabatrin Market Share in Value by Type (2024-2024)
Table 8. Global Vigabatrin Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Vigabatrin Sales by Type (2024-2034) & (K Units)
Table 10. Global Vigabatrin Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Vigabatrin Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Vigabatrin Sales Market Share in Value by Type (2024-2034)
Table 13. Global Vigabatrin Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Vigabatrin Sales by Type (2024-2024) & (K Units)
Table 15. North America Vigabatrin Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Vigabatrin Sales (K Units) by Type (2024-2024)
Table 17. Europe Vigabatrin Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Vigabatrin Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Vigabatrin Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Vigabatrin Sales (K Units) by Type (2024-2024)
Table 21. Latin America Vigabatrin Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Vigabatrin Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Vigabatrin Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Vigabatrin Sales by Company (2024-2024) & (K Units)
Table 25. Global Vigabatrin Sales Share by Company (2024-2024)
Table 26. Global Vigabatrin Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Vigabatrin Revenue Share by Company (2024-2024)
Table 28. Global Market Vigabatrin Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Vigabatrin Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Vigabatrin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vigabatrin as of 2022)
Table 32. Date of Key Manufacturers Enter into Vigabatrin Market
Table 33. Key Manufacturers Vigabatrin Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Vigabatrin Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Vigabatrin Sales by Region (2024-2024) & (K Units)
Table 37. Global Vigabatrin Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Vigabatrin Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Vigabatrin Sales Market Share in Value by Region (2024-2024)
Table 40. Global Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Vigabatrin Sales by Region (2024-2034) & (K Units)
Table 42. Global Vigabatrin Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Vigabatrin Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Vigabatrin Sales Market Share in Value by Region (2024-2034)
Table 45. Global Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Vigabatrin Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Vigabatrin Sales by Application (2024-2024) & (K Units)
Table 48. Global Vigabatrin Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Vigabatrin Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Vigabatrin Sales Market Share in Value by Application (2024-2024)
Table 51. Global Vigabatrin Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Vigabatrin Sales by Application (2024-2034) & (K Units)
Table 53. Global Vigabatrin Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Vigabatrin Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Vigabatrin Sales Market Share in Value by Application (2024-2034)
Table 56. Global Vigabatrin Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Vigabatrin Sales by Application (2024-2024) (K Units)
Table 58. North America Vigabatrin Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Vigabatrin Sales by Application (2024-2024) (K Units)
Table 60. Europe Vigabatrin Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Vigabatrin Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Vigabatrin Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Vigabatrin Sales by Application (2024-2024) (K Units)
Table 64. Latin America Vigabatrin Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Vigabatrin Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Vigabatrin Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Vigabatrin Sales by Country (2024-2024) & (K Units)
Table 68. North America Vigabatrin Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Vigabatrin Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Vigabatrin Sales Market Share in Value by Country (2024-2024)
Table 71. North America Vigabatrin Sales by Country (2024-2034) & (K Units)
Table 72. North America Vigabatrin Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Vigabatrin Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Vigabatrin Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Vigabatrin Sales by Country (2024-2024) & (K Units)
Table 76. Europe Vigabatrin Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Vigabatrin Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Vigabatrin Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Vigabatrin Sales by Country (2024-2034) & (K Units)
Table 80. Europe Vigabatrin Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Vigabatrin Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Vigabatrin Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Vigabatrin Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Vigabatrin Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Vigabatrin Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Vigabatrin Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Vigabatrin Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Vigabatrin Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Vigabatrin Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Vigabatrin Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Vigabatrin Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Vigabatrin Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Vigabatrin Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Vigabatrin Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Vigabatrin Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Vigabatrin Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Vigabatrin Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Vigabatrin Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Vigabatrin Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Vigabatrin Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Vigabatrin Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Vigabatrin Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Vigabatrin Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Vigabatrin Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Vigabatrin Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Vigabatrin Sales Market Share in Value by Country (2024-2034)
Table 107. Sanofi Company Information
Table 108. Sanofi Introduction and Business Overview
Table 109. Sanofi Vigabatrin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Sanofi Vigabatrin Product
Table 111. Sanofi Recent Development
Table 112. Benta Pharma Industries Company Information
Table 113. Benta Pharma Industries Introduction and Business Overview
Table 114. Benta Pharma Industries Vigabatrin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Benta Pharma Industries Vigabatrin Product
Table 116. Benta Pharma Industries Recent Development
Table 117. Dr. Fisher Farma Company Information
Table 118. Dr. Fisher Farma Introduction and Business Overview
Table 119. Dr. Fisher Farma Vigabatrin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Dr. Fisher Farma Vigabatrin Product
Table 121. Dr. Fisher Farma Recent Development
Table 122. Lundbeck Company Information
Table 123. Lundbeck Introduction and Business Overview
Table 124. Lundbeck Vigabatrin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Lundbeck Vigabatrin Product
Table 126. Lundbeck Recent Development
Table 127. Novartis Company Information
Table 128. Novartis Introduction and Business Overview
Table 129. Novartis Vigabatrin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Novartis Vigabatrin Product
Table 131. Novartis Recent Development
Table 132. Perrigo Company Information
Table 133. Perrigo Introduction and Business Overview
Table 134. Perrigo Vigabatrin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Perrigo Vigabatrin Product
Table 136. Perrigo Recent Development
Table 137. Grindeks Company Information
Table 138. Grindeks Introduction and Business Overview
Table 139. Grindeks Vigabatrin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Grindeks Vigabatrin Product
Table 141. Grindeks Recent Development
Table 142. Endo International Company Information
Table 143. Endo International Introduction and Business Overview
Table 144. Endo International Vigabatrin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Endo International Vigabatrin Product
Table 146. Endo International Recent Development
Table 147. Amneal Pharma Company Information
Table 148. Amneal Pharma Introduction and Business Overview
Table 149. Amneal Pharma Vigabatrin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Amneal Pharma Vigabatrin Product
Table 151. Amneal Pharma Recent Development
Table 152. Cipla Company Information
Table 153. Cipla Introduction and Business Overview
Table 154. Cipla Vigabatrin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Cipla Vigabatrin Product
Table 156. Cipla Recent Development
Table 157. Upsher-Smith Company Information
Table 158. Upsher-Smith Introduction and Business Overview
Table 159. Upsher-Smith Vigabatrin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Upsher-Smith Vigabatrin Product
Table 161. Upsher-Smith Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Vigabatrin Market Trends
Table 165. Vigabatrin Market Drivers
Table 166. Vigabatrin Market Challenges
Table 167. Vigabatrin Market Restraints
Table 168. Vigabatrin Distributors List
Table 169. Vigabatrin Downstream Customers
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Vigabatrin Product Picture
Figure 2. Global Vigabatrin Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Vigabatrin Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Vigabatrin Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Tablet
Figure 6. Global Tablet Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Powder
Figure 8. Global Powder Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Vigabatrin Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Vigabatrin Sales Market Share by Type in 2022 & 2034
Figure 11. North America Vigabatrin Sales Market Share in Volume by Type in 2022
Figure 12. North America Vigabatrin Sales Market Share in Value by Type in 2022
Figure 13. Europe Vigabatrin Sales Market Share in Volume by Type in 2022
Figure 14. Europe Vigabatrin Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Vigabatrin Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Vigabatrin Sales Market Share in Value by Type in 2022
Figure 17. Latin America Vigabatrin Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Vigabatrin Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Vigabatrin Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Vigabatrin Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Vigabatrin Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Vigabatrin Revenue in 2022
Figure 23. Vigabatrin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Infantile Spasms (IS)
Figure 25. Global Infantile Spasms (IS) Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Partial-Onset Seizures
Figure 27. Global Partial-Onset Seizures Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Refractory Complex Partial Seizures
Figure 29. Global Refractory Complex Partial Seizures Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Vigabatrin Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Vigabatrin Sales Market Share by Application in 2022 & 2034
Figure 32. North America Vigabatrin Sales Market Share in Volume by Application in 2022
Figure 33. North America Vigabatrin Sales Market Share in Value by Application in 2022
Figure 34. Europe Vigabatrin Sales Market Share in Volume by Application in 2022
Figure 35. Europe Vigabatrin Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Vigabatrin Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Vigabatrin Sales Market Share in Value by Application in 2022
Figure 38. Latin America Vigabatrin Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Vigabatrin Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Vigabatrin Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Vigabatrin Manufacturing Cost Structure
Figure 43. Vigabatrin Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed